Development of dual modified albumin with cyclic RGD peptide and <I>closo</I>-dodecaborates as an active tumor targeting boron agent for neutron capture therapy

Presentation information

Academic Program (AP)

Chemical Biology

Sun. Mar 17, 2019 1:30 PM - 4:50 PM F6 (356, Bldg. 3 [5F])

2F6-28～2F6-33　INUKI, Shinsuke
2F6-35～2F6-40　KUBOTA, Ryou
2F6-42～2F6-46　SATO, Shinichi

3:10 PM - 3:20 PM

[2F6-38] Development of dual modified albumin with cyclic RGD peptide and closo-dodecaborates as an active tumor targeting boron agent for neutron capture therapy

○KAWAI, Kazuki; SATO, Shinichi; NAKAMURA, Hiroyuki (Lab. Chem. Life Sci., Tokyo Tech.; Sch. Life Sci. Tech., Tokyo Tech.)

PC Setting Time : 14:30 - 14:40

Keywords:cancer、boron cluster、cyclic RGD peptide、albumin、active targeting

Please log in with your participant account.
» Participant Log In